Alphatec Holdings, Inc., through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A.S. and SafeOp Surgical, Inc., is a medical device company. The Company is focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. The Company's Organic Innovation Machine is focused on developing new approaches that integrate with its expanding Alpha InformatiX (AIX) Platform to better inform surgery and safely and reproducibly achieve the goals of spine surgery. Its technologies include AIX, positioners, access systems, implants and fixation systems, and biologics. Its AIX product platform comprises its EOS imaging system and VEA alignment mobile application, its SafeOp Neural InformatiX System and its navigation-enabled robotics platform (Valence). It has developed approach-specific patient positioning systems that integrate with its other access systems, providing for a more rigid construct and enhanced reproducibility.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 58.45% year-on-year.
Undervalued
The company’s latest PE is -11.34, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 120.50M shares, decreasing 0.23% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 302.68K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of 0.05.